Lanean...
Preclinical Pharmacokinetic Considerations for the Development of Antibody Drug Conjugates
Antibody drug conjugates (ADCs) are an emerging new class of targeted therapeutics for cancer that use antibodies to deliver cytotoxic drugs to cancer cells. There are two FDA approved ADCs on the market and over 30 ADCs in the clinical pipeline against a number of different cancer types. The struct...
Gorde:
| Argitaratua izan da: | Pharm Res |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer US
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4596897/ https://ncbi.nlm.nih.gov/pubmed/25446773 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-014-1584-z |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|